BamSEC and AlphaSense Join Forces
Learn More

Rallybio Corporation – Transcripts

NASDAQ: RLYB    
Share price (6/1/26): $16.87    
Market cap (6/1/26): $89.4 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
M&A Revised 06/01/26 Rallybio Corporation, Avenzo Therapeutics, Inc. - M&A Call 06/01/26
M&A Revised 03/02/26 Rallybio Corporation, Candid Therapeutics, Inc. - M&A Call 03/02/26
CY 2024
Other Revised 12/02/24 Rallybio Corporation - Special Call 12/02/24
Other Revised 01/10/24 Rallybio Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 08:15 AM 01/10/24
CY 2023
Other Revised 12/20/23 Rallybio Corporation - Special Call 12/20/23
Other Revised 06/26/23 Rallybio Corporation - Shareholder/Analyst Call 06/24/23
Other Revised 01/10/23 Rallybio Corporation Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 03:45 PM 01/10/23